Bryan D. Choi

Harvard University — United States

Medicine · Health Sciences

36h-index6.4kcitations334works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(165), Cancer Immunotherapy and Biomarkers(59), Glioma Diagnosis and Treatment(50), Monoclonal and Polyclonal Antibodies Research(39), Immune Cell Function and Interaction(35)

Publications334 total

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma
Journal of Hematology & Oncology·2026Open Access
Tumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy
Neuro-Oncology·2025
Immunotherapy and targeted therapy for high grade gliomas: current and future directions
Journal of Neuro-Oncology·2025
Supplementary Data 1 from Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients
2025Open Access
280 Cell atlas-resolved discovery and targeting of novel CAR antigens in anaplastic thyroid carcinoma
Regular and Young Investigator Award Abstracts·2025Open Access
NCMP-17. Clinical Presentation, Management and Outcome of Tumor inflammation-associated neurotoxicity (TIAN) in CNS lymphoma treated with CD19-CAR T-cell therapy
Neuro-Oncology·2025Open Access
IMMU-38. Single-cell RNA sequencing of cerebrospinal fluid in CARv3-TEAM-E treated glioblastoma
Neuro-Oncology·2025Open Access
EXTH-47. Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Neuro-Oncology·2025Open Access
Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
Genomic correlates of clinical CAR-T cell activity
2025Open Access
Departments of Neurosurgery are Leaders in Highly Cited Glioblastoma Research
Neurosurgery Open·2025Open Access
Early exposure to neurosurgery: promoting early specialty interest through a single-day resident-driven neurosurgical course for preclinical students
Journal of Clinical Neuroscience·2025
Translational advancements in tumor vaccine therapies for glioblastomas
Neuro-Oncology Advances·2025· 1 citedOpen Access
Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability
Cytotherapy·2025Open Access
Supplementary Figure 7 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
Supplementary Figure 13 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
Supplementary Figure 3 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
Supplementary Figure 12 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
Supplementary Figure 11 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
Supplementary Figure 4 from Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency
2025Open Access
page 1 of 17Next →

Frequent Co-authors

John H. Sampson(21), Marcela V. Maus(16), Darell D. Bigner(14), Luis Sánchez-Pérez(12), Rebecca C. Larson(10), Matthew J. Frigault(10), Amanda A. Bouffard(9), Mark B. Leick(9), William T. Curry(9), Carter M. Suryadevara(9), Patrick C. Gedeon(9), Andrea Schmidts(8), Irene Scarfò(8), James E. Herndon(8), Gary E. Archer(8), Stefanie R. Bailey(7), Bob S. Carter(6), Ana P. Castaño(5), Angela C. Boroughs(5), Kathleen Gallagher(5)